Clearstead Advisors’s Advent Technologies ADN Stock Holding History

Clearstead Advisors’s Portfolio ADN Stock Details ADN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-91	Closed	-$37K	–	1249
2021 Q1	$37K	Buy	+91	New	+$41.2K	﹤0.01%	585

Other funds holding ADN

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Helikon Investments London, United Kingdom $2.65B AUM 79.03% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PSCM

Prince Street Capital Management New York $40.3M AUM 0.66% 1-Year Est. Return

EIM

Elephas Investment Management Hong Kong $367M AUM 189.12% 1-Year Est. Return

Clearstead Advisors's ADN Position: Q2 2021 in Review

Clearstead Advisors sold out of Advent Technologies (ADN) in Q2 2021, closing a stake of 91 shares — an estimated $37K sold.

Clearstead Advisors first reported a position in ADN in Q1 2021 and held it in 1 quarter. The position peaked at $37K in Q1 2021. 49 funds tracked by Wall St. Rank hold ADN as of Q2 2021.

Clearstead Advisors reported no remaining Advent Technologies position as of Q2 2021 after selling out during the quarter.
Clearstead Advisors sold 91 Advent Technologies shares in Q2 2021, an estimated $37K.
Clearstead Advisors first reported a position in Advent Technologies in Q1 2021 and held it in 1 quarter.
Clearstead Advisors's Advent Technologies position peaked at $37K in Q1 2021.
49 funds tracked by Wall St. Rank held Advent Technologies as of Q2 2021.

Based on Clearstead Advisors's 13F filing for Q2 2021, filed 12 Aug 2021.